Biolase Inc Expected To Post A Loss Of 62 Cents A Share: Earnings Preview

November 26

10/08/2022 03:01

* BIOLASE Inc  BIOL.OQ   BIOL.O  is expected to show a rise
in
quarterly revenue when it reports  results on August 11. 
    * The Foothill Ranch California-based  company is expected
to
report  a 16.3% increase in revenue to $10.627 million from
$9.13 million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for BIOLASE Inc is for
a loss
of 62 cents per share. For the same quarter last year, the
company reported a loss of 50 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for BIOLASE Inc
is
$18.5​, above​ its last closing price of $5.45. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.79       -0.68      -0.81     Missed  -19.1
 Dec. 31 2022              -0.62      -0.75     Missed  -20
 Sep. 30 2021  -0.62       -0.69      -0.50     Beat    27.3​
 Jun. 30 2021  -1.13       -1.08      -0.50     Beat    53.8
 ​​Mar.        -1.25       -1.25      -1.50     Missed  -20
 31 2021                                                
 Dec. 31 2020  -1.00       -0.92      -1.75     Missed  -90.9​
 Sep. 30 2020  -1.25       -1.33      -1.25     Beat    6.2
 Jun. 30 2020  -4.32       -4.25      -3.00     Beat    29.4
 This summary was machine generated August 10 at 02:01 GMT.  All
figures in US dollars  unless otherwise stated